1,138
Views
0
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Evaluation of analytical and clinical performance of the AFIAS Tn-I plus assay - a new point-of-care

, , , &
Pages 351-357 | Received 01 Sep 2023, Accepted 16 Nov 2023, Published online: 30 Nov 2023

References

  • Chapman AR, Adamson PD, Shah ASV, et al. High-sensitivity cardiac troponin and the universal definition of myocardial infarction. Circulation. 2020;141(3):161–171. doi: 10.1161/CIRCULATIONAHA.119.042960.
  • Sandoval Y, Apple FS, Mahler SAet al. High-sensitivity cardiac troponin and the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guidelines for the evaluation and diagnosis of acute chest pain. Circulation. 2022;146(7):569–581. doi: 10.1161/CIRCULATIONAHA.122.059678.
  • Collet JP, Thiele H, Barbato E, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi: 10.1093/eurheartj/ehaa575.
  • Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–3826.
  • Hight M, Conklin K, Archer B, et al. Implementing point-of-care troponin testing in the emergency department: impact on time to result. J Emerg Nurs. 2021;47(2):299–304. doi: 10.1016/j.jen.2020.06.014.
  • Boeddinghaus J, Nestelberger T, Koechlin L, et al. Early diagnosis of myocardial infarction with point-of-care high-sensitivity cardiac troponin I. J Am Coll Cardiol. 2020;75(10):1111–1124. doi: 10.1016/j.jacc.2019.12.065.
  • Cullen L, Collinson PO, Giannitsis E. Point-of-care testing with high-sensitivity cardiac troponin assays: the challenges and opportunities. Emerg Med J. 2022;39(11):861–866. doi: 10.1136/emermed-2021-211907.
  • Sandoval Y, Apple FS. The global need to define normality: the 99th percentile value of cardiac troponin. Clin Chem. 2014;60(3):455–462. doi: 10.1373/clinchem.2013.211706.
  • Collinson P, Aakre KM, Saenger A, et al. Cardiac troponin measurement at the point of care: educational recommendations on analytical and clinical aspects by the IFCC committee on clinical applications of cardiac Bio-Markers (IFCC C-CB). Clin Chem Lab Med. 2023;61(6):989–998. doi: 10.1515/cclm-2022-1270.
  • Apple FS, Wu AHB, Sandoval Y, et al. Sex-specific 99th percentile upper reference limits for high sensitivity cardiac troponin assays derived using a universal sample bank. Clin Chem. 2020;66(3):434–444. doi: 10.1093/clinchem/hvz029.
  • Apple FS, Schulz K, Schmidt CW, et al. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay. Clin Chem Lab Med. 2021;59(9):1574–1578. doi: 10.1515/cclm-2021-0262.
  • McEvoy JW, Tang O, Wang D, et al. Myocardial injury thresholds for 4 High-Sensitivity troponin assays in U.S. Adults. J Am Coll Cardiol. 2023;81(20):2028–2039. doi: 10.1016/j.jacc.2023.03.403.
  • Thygesen K, Alpert JS, Jaffe AS et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618–e651. doi: 10.1161/CIR.0000000000000617.
  • Wu AHB, Christenson RH, Greene DN, et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the academy of the American association for clinical chemistry and the task force on clinical applications of cardiac bio-markers of the international federation of clinical chemistry and laboratory medicine. Clin Chem. 2018;64(4):645–655. doi: 10.1373/clinchem.2017.277186.
  • Aakre KM, Saenger AK, Body R, et al. Analytical considerations in deriving 99th percentile upper reference limits for high-sensitivity cardiac troponin assays: educational recommendations from the IFCC committee on clinical application of cardiac Bio-Markers. Clin Chem. 2022;68(8):1022–1030. doi: 10.1093/clinchem/hvac092.
  • Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem. 2009;55(7):1303–1306. doi: 10.1373/clinchem.2009.128363.
  • IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB). High Sensitivity Cardiac Troponin I and T Assay Analytical Characteristics Designated by Manufacturer. https://www.ifcc.org/media/479435/high-sensitivity-cardiac-troponin-i-and-t-assay-analyticalcharacteristics-designated-by-manufacturer-v052022.pdf. (accessed August 24, 2023).
  • IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB). High Sensitivity Cardiac Troponin I and T Assay Analytical Characteristics Designated by Manufacturer. https://ifcc.web.insd.dk/media/479438/point-of-care-cardiac-troponin-i-and-t-assay-analytical-characteristics-designated-by-manufacturer-v052022.pdf. (accessed August 24, 2023).
  • Hasselbalch RB, Kristensen JH, Jørgensen N, et al. High incidence of discrepancies in new siemens assay - a comparison of cardiac troponin I assays. Clin Chem Lab Med. 2022;60(6):921–929. doi: 10.1515/cclm-2022-0034.
  • Masotti S, Musetti V, Prontera C, et al. Evaluation and comparison with other high-sensitivity methods of analytical performance and measured values of a new laboratory test for cardiac troponin I assay. J Appl Lab Med. 2021;6(5):1237–1250. doi: 10.1093/jalm/jfab017.
  • Tate JR, Bunk DM, Christenson RH, et al. Evaluation of standardization capability of current cardiac troponin I assays by a correlation study: results of an IFCC pilot project. Clin Chem Lab Med. 2015;53(5):677–690. doi: 10.1515/cclm-2014-1197.